Results 251 to 260 of about 1,086,001 (306)

The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing?

Dermatology, 2021
Background: Dermatophytosis is commonly encountered in the dermatological clinics. The main aetiological agents in dermatophytosis of skin and nails in humans are Trichophyton (T.) rubrum, T. mentagrophytes and T. interdigitale (former T.
J. Shen, M. Arendrup, S. Verma, D. Saunte   +3 more
semanticscholar   +1 more source

How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton.

Clinical Microbiology and Infection, 2020
BACKGROUND Antifungal drug resistance in dermatophytes was first reported shortly after the turn of the millennium and has today been reported in Trichophyton and occasionally in Microsporum, but not in Epidermophyton species. Although drug resistance in
M. Arendrup, G. Kahlmeter, J. Guinea, J. Meletiadis   +3 more
semanticscholar   +1 more source

Antifungal Susceptibility Testing

Infectious Disease Clinics of North America, 2006
Antifungal susceptibility testing has been in routine use now for more than 15 years and has become a useful tool for clinicians who are faced with difficult treatment decision. Although most clinicians order susceptibility testing, much confusion still exists regarding the use of the results.
Annette W, Fothergill, Michael G, Rinaldi, Deanna A, Sutton   +2 more
openaire   +2 more sources

Antifungal Susceptibility Testing Methods

Current Drug Targets, 2005
The number of systemically active antifungal agents has increased dramatically in recent years in response to the challenge of invasive mycoses. Additional work is needed to better understand the mechanisms of action of these agents as well as the mechanisms of resistance expressed by the fungal pathogens.
openaire   +2 more sources

In Vitro Antifungal Susceptibility Testing

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
With the rising frequency of fungal infections, as well as increasing reports of resistance to antifungal agents, it is imperative that clinically applicable antifungal susceptibility testing be available. In 1997 the National Committee for Clinical Laboratory Standards published standard guidelines for antifungal susceptibility testing of Candida sp ...
H L, Hoffman, M A, Pfaller
openaire   +2 more sources

Antifungal Susceptibility Testing in Teaching Hospitals

Annals of Pharmacotherapy, 2003
BACKGROUND: An assessment of antifungal susceptibility testing (AST) has not been conducted since the introduction of the National Committee for Clinical Laboratory Standards (NCCLS) M27-A document. OBJECTIVE: To determine AST practices in teaching hospitals.
Manjunath P, Pai, Susan L, Pendland
openaire   +2 more sources

Antifungal Drug Susceptibility Testing

1989
The continuing introduction of new antifungal drugs has increased the demand for methods of in vitro testing that can predict the effects of compounds in vivo. As with antibacterial drugs, tests designed to ascertain the minimum amount of drug needed to inhibit the growth of organisms in vitro (minimum inhibitory concentration, or MIC) have often been ...
openaire   +2 more sources

Antifungal Agents and Antifungal Susceptibility Testing

2010
1 Systemic Antifungal Drugs in Current Use 2 Future Antifungal Drugs 3 Antifungal Susceptibility Testing 4 Methods of Susceptibility Testing Keywords: antifungal agents and antifungal susceptibility testing; systemic antifungal drugs in current use; antifungal mechanisms of action; lipid vehicles for polyenes; unique ...
Sanjay G. Revankar, John R. Graybill, Thomas F. Patterson   +2 more
openaire   +1 more source

Antifungal susceptibility profiles of rare ascomycetous yeasts.

Journal of Antimicrobial Chemotherapy, 2019
OBJECTIVES To generate antifungal susceptibility patterns for Trichomonascus ciferrii (Candida ciferrii), Candida inconspicua (Torulopsis inconspicua) and Diutina rugosa species complex (Candida rugosa species complex), and to provide key parameters such
A. Pérez-Hansen, C. Lass‐Flörl, M. Lackner   +2 more
semanticscholar   +1 more source

Aspergillus – Classification and Antifungal Susceptibilities

Current Pharmaceutical Design, 2013
Aspergillus is one of the most important fungal genera for the man, for its industrial use, its ability to spoil food and not least its medical impact as cause of a variety of diseases. Currently hundreds of species of Aspergillus are known; nearly fifty of them are able to cause infections in humans and animals.
openaire   +2 more sources